Fondaparinux

Common brands: Arixtra, Lasix, Ecotrin, Aspirin, Aspirin 325 Mg

Top reporter: Mylan Institutional Llc

Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]Loop Diuretic [EPC]Benzodiazepine [EPC]Platelet Aggregation Inhibitor [EPC]
8,014
Total Reports
2,104
Serious Reports
1,437
Death Reports
30
Reported Reactions
Death Report Ratio: High (17.93%)

Patient Demographics

Male
3,174
Female
4,147

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Fondaparinux.

# Reaction Reports % of Total
1 ANAEMIA 610
7.8%
2 HAEMATOMA 559
7.2%
3 PULMONARY EMBOLISM 443
5.7%
4 OFF LABEL USE 366
4.7%
5 HAEMORRHAGE 350
4.5%
6 HAEMOGLOBIN DECREASED 339
4.3%
7 DEATH 296
3.8%
8 DEEP VEIN THROMBOSIS 293
3.8%
9 DYSPNOEA 270
3.5%
10 THROMBOCYTOPENIA 262
3.4%
11 DRUG INEFFECTIVE 258
3.3%
12 PYREXIA 241
3.1%
13 NAUSEA 234
3.0%
14 THROMBOSIS 233
3.0%
15 VOMITING 231
3.0%
16 DRUG INTERACTION 229
2.9%
17 DIARRHOEA 216
2.8%
18 MUSCLE HAEMORRHAGE 215
2.8%
19 CEREBRAL HAEMORRHAGE 208
2.7%
20 ABDOMINAL PAIN 206
2.6%
21 PAIN IN EXTREMITY 193
2.5%
22 INCORRECT DRUG ADMINISTRATION DURATION 189
2.4%
23 HYPOTENSION 184
2.4%
24 ASTHENIA 177
2.3%
25 SHOCK HAEMORRHAGIC 174
2.2%
26 OEDEMA PERIPHERAL 170
2.2%
27 PAIN 165
2.1%
28 MELAENA 164
2.1%
29 FALL 163
2.1%
30 HEADACHE 160
2.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.